Clinical Trial Update: Clinical Trial Using the Proteolytic Fraction P1G10 From V. Cundinamarcensis to Heal Diabetic Foot Ulcer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating P1G10 proteolytic fraction from V. cundinamarcensis for healing diabetic foot ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot
• Diabetic Neuropathy
• Foot Ulcer

Drugs mentioned

• P1G10 proteolytic fraction from V. cundinamarcensis

Snippet

Sponsor: Carlos E Salas | Conditions: Diabetic Foot, Neuropathy, Diabetic | Phase 2 | Status: COMPLETED